Evidence map›Paper›PMID 22911867›Full record

ArticlePloS one2012

Copy number variation and differential expression of a protective endogenous retrovirus in sheep.

Barbara Viginier, Christine Dolmazon, Isabelle Lantier, Frédéric Lantier, Fabienne Archer, Caroline Leroux, Christophe Terzian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. HIV infection en route to endogenization: two cases.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2014
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Barbara ViginierUMR754 Rétrovirus et Pathologie Comparée INRA, Université Lyon 1, Université de Lyon, Lyon, France.
Christine Dolmazon
Isabelle Lantier
Frédéric Lantier
Fabienne Archer
Caroline Leroux
Christophe Terzian
Université Claude Bernard Lyon 1 · FRCentre Val de Loire · FRÉcole Pratique des Hautes Études · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Jaagsiekte sheep retrovirus exJSRV and its endogenous counterpart enJSRV co-exist in sheep. exJSRV, a betaretrovirus, is the etiological agent of ovine pulmonary adenocarcinoma, and it has been demonstrated in vitro that an enJSRV Gag variant bearing the R-to-W amino acid change at position 21 was able to block exJSRV budding from the cells, providing a potential protective role for the host. In this work, we developed a fast mutation detection assay based on the oligo ligation assay (OLA) that permits the quantification of the relative proportions of the R21 and W21 Gag variants present in individual genomes and in cDNA obtained from normal and exJSRV-induced lung tumors. We have shown that the W21/R21 ratio is variable within and between breeds. We also describe for the first time that putative protecting enJSRV variants were expressed in alveolar type II cells (AECII), the major target of exJSRV.

Indexed as

Gene Expression Regulation, ViralAnimalsBase SequenceDNA Copy Number VariationsDNA, NeoplasmEndogenous RetrovirusesGene Products, gagGenomeInbreedingJaagsiekte sheep retrovirusLungMolecular Sequence DataMutant ProteinsMutationProvirusesPulmonary Adenomatosis, OvineDNA, NeoplasmGene Products, gagMutant ProteinsRNA, Neoplasm

Identifiers

PMID22911867
PMCPMC3404005
OpenAlexW1965365001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.